Intermolecular, which aids in developing intellectual property for companies in the semiconductor and clean energy market, announced terms for its IPO on Monday. The San Jose, CA-based company plans to raise $130 million by offering 10 million shares at a price range of $12.00 to $14.00. At the mid-point of the proposed range, Intermolecular will command a market value of $643 million. Intermolecular, which was founded in 2004 and booked $53 million in revenues for the 12 months ended June 30, 2011, plans to list on the NASDAQ under the symbol IMI. Morgan Stanley, J.P. Morgan, and Barclays Capital are the lead underwriters on the deal, which is expected to price during the week of November 14.
